The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicodemographic predictors of enrollment and outcomes in early phase oncology clinical trials in a diverse urban population.
 
Anna Argulian
No Relationships to Disclose
 
Grace Van Hyfte
No Relationships to Disclose
 
Elena Baldwin
No Relationships to Disclose
 
Ashwin Kulshrestha
No Relationships to Disclose
 
Natalie Lucas
Employment - Mount Sinai University Medical Center and School of Medicine
 
Jessica Wilk
No Relationships to Disclose
 
Kathy Wu
No Relationships to Disclose
 
Megan Yuan
No Relationships to Disclose
 
Gabriela Fazilov
No Relationships to Disclose
 
Lisa Fitzgerald
No Relationships to Disclose
 
Olivia Hapanowicz
Employment - Mount Sinai Hospital; Mount Sinai Hospital; Mount Sinai Hospital
 
Melissa Osorio
No Relationships to Disclose
 
Jordan Cuevas
No Relationships to Disclose
 
Aleksandra Wawrzyniak
No Relationships to Disclose
 
Ana Acuna-Villaorduna
No Relationships to Disclose
 
Dmitriy Zamarin
Leadership - Accurius
Stock and Other Ownership Interests - Accurius; Calidi Biotherapeutics; ImmunOs Therapeutics
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Daiichi Sankyo/Lilly; Everest Medicine; Genentech/Roche; Gilead Sciences; Hervolution; Memgen; Miltenyi Biotec; Takeda; Xencor
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); Synthekine (Inst)
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
 
Dan Feng
No Relationships to Disclose
 
Matthew Galsky
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Curis; Daiichi Sankyo Europe GmbH; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
Thomas Marron
Consulting or Advisory Role - Abbvie; Arrowhead Pharmaceuticals; Astellas Pharma; AstraZeneca; Avammune; EMD Serono; Geneos; Merck; Regeneron; Replimune; Replimune; Storm Therapeutics
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - Patent on the combined use of IL4 blockade and PD-1 blockade. (Inst); Patient on the neoadjuvant use of cemiplimab for the treatment of HCC
Travel, Accommodations, Expenses - Abbvie; Genentech
 
Deborah Doroshow
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Atheneum; Boehringer Ingelheim; Dedham Group; G1 Therapeutics; MJH Life Sciences; Sanofi; Sonata Therapeutics; Summit Therapeutics; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; MJH Life Sciences
Other Relationship - Bristol Myers Squibb Foundation; Conquer Cancer Foundation